Trials / Completed
CompletedNCT02484482
Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)
A Randomized, Open-label, Single Dose, 3-treatment, 3-period, 6-sequence Crossover Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519 After Oral Administration in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose this study investigate the effect of food on the pharmacokinetics/pharmacodynamics and safety of CKD-519
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-519 200mg / Fasting, Standard Meal, High Fat Meal |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-06-29
- Last updated
- 2015-12-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02484482. Inclusion in this directory is not an endorsement.